Symbol | Preis | Veränderung % | Volumen | Relatives Volumen | Marktkapitalisierung | KGV | EPS-Verd. TTM | EPS-Verd. Wachstum TTM YoY | Dividendenrendite % TTM | Analysten-Rating |
---|---|---|---|---|---|---|---|---|---|---|
AABSARCTIC BIOSCIENCE AS | 9.08 NOK | −1.30% | 11.4 K | 1.39 | 230.356 M NOK | — | −1.79 NOK | −2.38% | 0.00% | Kauf |
AZTARCTICZYMES TECHNOLOGIES ASA | 29.50 NOK | +0.85% | 5.971 K | 0.17 | 1.488 B NOK | 79.97 | 0.37 NOK | −42.72% | 0.00% | Neutral |
BGBIOBERGENBIO ASA | 0.1610 NOK | −6.61% | 31.004 M | 0.85 | 463.53 M NOK | — | −0.35 NOK | +8.31% | 0.00% | Neutral |
BMKBENCHMARK HLDGS PLC | 6.75 NOK | +12.50% | 50 | 0.00 | 4.553 B NOK | — | −0.52 NOK | −9.86% | 0.00% | Kauf |
CCIRCACIRCA GROUP AS | 1.245 NOK | −6.74% | 195.896 K | 0.95 | 162.576 M NOK | — | −0.55 NOK | −9.89% | 0.00% | — |
CCRNACIRCIO HOLDING ASA | 6.684 NOK | +11.40% | 41.957 K | 0.48 | 47.633 M NOK | — | — | — | 0.00% | — |
EEXTXEXACT THERAPEUTICS AS | 9.95 NOK | −0.50% | 150 | 0.08 | 319.201 M NOK | — | −1.20 NOK | — | 0.00% | — |
GGENTGENTIAN DIAGNOSTICS ASA | 38.1 NOK | −0.52% | 2.852 K | 0.88 | 590.676 M NOK | — | −0.67 NOK | +56.15% | 0.00% | Starker Kauf |
LIFELIFECARE AS | 3.09 NOK | +5.82% | 208.831 K | 1.15 | 393.808 M NOK | — | −0.29 NOK | −68.76% | 0.00% | — |
LYTIXLYTIX BIOPHARMA AS | 6.70 NOK | +4.69% | 8.254 K | 0.19 | 256.437 M NOK | — | −2.19 NOK | — | 0.00% | — |
MEDIMEDISTIM ASA | 192.0 NOK | +0.52% | 110 | 0.03 | 3.479 B NOK | 33.83 | 5.68 NOK | −8.98% | 2.36% | Verkauf |
NTGNORDIC TECHNOLOGY GROUP AS | 3.00 NOK | +3.45% | 50 K | 3.08 | — | — | −1.80 NOK | — | 0.00% | — |
NYKDNYKODE THERAPEUTICS ASA | 14.19 NOK | +1.87% | 653.085 K | 0.33 | 4.549 B NOK | — | −1.27 NOK | +10.96% | 0.00% | Starker Kauf |
PCIBPCI BIOTECH HOLDING ASA | 1.678 NOK | −5.73% | 28.515 K | 0.20 | 66.441 M NOK | — | −0.78 NOK | +65.42% | 0.00% | — |
PHOPHOTOCURE ASA | 62.0 NOK | +3.68% | 358.138 K | 3.33 | 1.621 B NOK | 6458.33 | 0.01 NOK | — | 0.00% | Starker Kauf |
ULTIULTIMOVACS ASA | 7.02 NOK | −5.14% | 1.434 M | 0.29 | 254.534 M NOK | — | −5.93 NOK | −35.75% | 0.00% | Verkauf |
VISTNVISTIN PHARMA ASA | 22.5 NOK | 0.00% | 21.981 K | 1.53 | 997.753 M NOK | — | — | — | 0.00% | — |